270 related articles for article (PubMed ID: 28180923)
1. Early assessment of coagulation necrosis after hepatic microwave ablation: a comparison of non-enhanced and enhanced T1-weighted images.
Jia ZY; Chen QF; Yang ZQ; Wu WT; Shi HB; Liu S
Abdom Radiol (NY); 2017 Jun; 42(6):1781-1787. PubMed ID: 28180923
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
3. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones.
Rempp H; Unterberg J; Hoffmann R; Pereira PL; Schick F; Claussen CD; Clasen S
Invest Radiol; 2013 Jun; 48(6):429-36. PubMed ID: 23511192
[TBL] [Abstract][Full Text] [Related]
4. Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response.
Kierans AS; Elazzazi M; Braga L; Leonardou P; Gerber DA; Burke C; Qureshi W; Kanematsu M; Semelka RC
AJR Am J Roentgenol; 2010 Feb; 194(2):523-9. PubMed ID: 20093619
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety and feasibility of ultrasound-guided percutaneous microwave ablation for large hepatic hemangioma.
Tang XY; Wang Z; Wang T; Cui D; Zhai B
J Dig Dis; 2015 Sep; 16(9):525-30. PubMed ID: 24945806
[TBL] [Abstract][Full Text] [Related]
6. Microwave ablation of liver tumors: degree of tissue contraction as compared to RF ablation.
Lee JK; Siripongsakun S; Bahrami S; Raman SS; Sayre J; Lu DS
Abdom Radiol (NY); 2016 Apr; 41(4):659-66. PubMed ID: 27039193
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies.
Weiss J; Rempp H; Clasen S; Notohamiprodjo M; Keßler DE; Pereira PL; Blumenstock G; Nikolaou K; Hoffmann R
Eur J Radiol; 2017 Sep; 94():85-92. PubMed ID: 28655432
[TBL] [Abstract][Full Text] [Related]
8. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P
Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
Kang TW; Rhim H; Lee J; Song KD; Lee MW; Kim YS; Lim HK; Jang KM; Kim SH; Gwak GY; Jung SH
Eur Radiol; 2016 Oct; 26(10):3437-46. PubMed ID: 26747262
[TBL] [Abstract][Full Text] [Related]
12. Assessment of liver ablation using cone beam computed tomography.
Abdel-Rehim M; Ronot M; Sibert A; Vilgrain V
World J Gastroenterol; 2015 Jan; 21(2):517-24. PubMed ID: 25593467
[TBL] [Abstract][Full Text] [Related]
13. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?
Watanabe H; Kanematsu M; Goshima S; Yoshida M; Kawada H; Kondo H; Moriyama N
AJR Am J Roentgenol; 2012 Mar; 198(3):589-95. PubMed ID: 22357997
[TBL] [Abstract][Full Text] [Related]
14. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
15. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
Merkle EM; Nour SG; Lewin JS
Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging.
Khankan AA; Murakami T; Onishi H; Matsushita M; Iannaccone R; Aoki Y; Tono T; Kim T; Hori M; Osuga K; Passariello R; Nakamura H
J Magn Reson Imaging; 2008 Mar; 27(3):546-51. PubMed ID: 18183580
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology.
Oyama Y; Nakamura K; Matsuoka T; Toyoshima M; Yamamoto A; Okuma T; Ikura Y; Ueda M; Inoue Y
Cardiovasc Intervent Radiol; 2005; 28(3):346-53. PubMed ID: 15886942
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging-guided microwave ablation of hepatic malignancies: Feasibility, efficacy, safety, and follow-up.
Yang N; Gong J; Yao L; Wang C; Chen J; Liu J; Wang Z; Lu J
J Cancer Res Ther; 2020 Sep; 16(5):1151-1156. PubMed ID: 33004763
[TBL] [Abstract][Full Text] [Related]
19. The tumor ghost on MRI after microwave ablation for hepatocellular carcinoma: A new modality to assess the ablative margin.
Liu S; Wu J; Ding W; Zhang C; Luo Y; Bai X; Wen K; Han Z; Yu J; Liang P
Eur J Radiol; 2023 Jan; 158():110617. PubMed ID: 36463706
[TBL] [Abstract][Full Text] [Related]
20. CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.
Asvadi NH; Anvari A; Uppot RN; Thabet A; Zhu AX; Arellano RS
J Vasc Interv Radiol; 2016 Apr; 27(4):496-502; quiz 503. PubMed ID: 26922977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
